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Summary
Prions, responsible for such neurodegenerative
diseases as mad-cow disease and scrapie, are
proteins that transmit a trait without the use of
conventional genetic material (DNA or RNA).
Prions’ infectivity arises from their tendency to
adopt an altered conformation that induces the
normally folded prion protein to change its shape
as well. My lab started out studying yeast protein
chaperones, which help proteins fold properly or, in
the event of environmental stress, refold properly.
One chaperone, Hsp104, has the unique role of
breaking up protein aggregates. The discovery that
Hsp104 mediates a yeast phenotype, called [PSI+],
that shows a prion-like pattern of inheritance
altered the course of my work dramatically. My lab
has since found that [PSI+] arises from the altered
conformation of a translation termination factor,
Sup35, resulting in insoluble aggregates.
Paradoxically, either deletion or overexpression of
Hsp104 abolishes [PSI+]. One of our more
astounding findings was that whereas mammalian
prions are harmful, yeast prions can be beneficial.
In one fungus, prions are even essential for survival
during part of its life cycle. Thus, in addition to
providing a simple system in which to study prion
genetics, yeast has broadened our view of prion
function overall.
Introduction
Prions were first discovered as the infectious agents
responsible for such neurogenerative diseases as
scrapie, mad cow disease, and Creuzfeldt-Jakob
disease1. They incited immediate interest and
controversy since they appeared to pass on the disease
phenotype without the use of DNA or RNA, henceforth
considered the only molecules capable of passing on a
trait.
The prion hypothesis, set forth by Stanley
Prusiner, states that prions propogate themselves via a
protein-only mechanism in which prion protein of an
altered conformation induces normally folded proteins
to adopt the prion form1. The prion protein in mammals
is called PrP and appears to be solely responsible for a
host of diseases with differing pathologies1.
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Protein chaperones are proteins that help
other proteins acquire their proper conformation2. Many
chaperones are upregulated in response to such
environmental stressors as heat, metals, and ethanol3,
hence the common prefix Hsp (heat-shock protein).
Several families of protein chaperones have been
identified, including hsp110, hsp100, hsp90, hsp70,
hsp60, hsp40, hsp10, and small hsp’s3. Hsp70, with the
help of Hsp40, binds to proteins as they are being
made by the ribosome to prevent inappropriate folding
before complete protein synthesis2. Hsp60 is a barrel-
shaped structure that acts to sequester misfolded
proteins from other proteins, giving them a chance to
refold without risk of aggregation2.
This review charts the course of my work
over the past 13 years, and the remarkable turn it took
when two seemingly unrelated fields collided.
A novel chaperone, a novel function
My lab started out attempting to identify and
characterize protein chaperones in yeast. One question
we addressed was that of thermotolerance. Although
yeast prefer to grow at 25°C, they are able to withstand
long periods at significantly higher temperatures.
Because chaperones help cells survive exposure to
stressors such as heat, it seemed logical that a
chaperone would be responsible for this
thermotolerance.
We sought out the protein responsible for this
thermotolerance by comparing the proteins present in
yeast cells grown at 25°C and cells that had been heat
shocked by growing at 39°C. In addition to a few known
chaperones, one previously unidentified 104-kilodalton
(kDa) protein was upregulated4. We named this protein
Hsp1044.
Hsp104 is part of the highly conserved
Hsp100 gene family5, homologues of which are present
in bacteria, trypanosomes, plants, fungi, and
mammals5,6. Its two ATP-binding sites show high
similarity to the bacterial ClpA/ClpB proteases and are
both essential for proper function5.
Studies on hsp104 nul l  mutants
demonstrated the many key roles that this protein
plays. Hsp104 is responsible for endowing spores with
their ability to withstand extreme heat7 and is essential
in growing cells for what is known as induced
thermotolerance. Induced thermotolerance results when
cells are gradually shifted to high termperatures, versus
basal thermotolerance, which is measured by shifting
from normal temperatures to high temperatures
directly4. Hsp104 is also upregulated in response
to ethanol and certain metals, bringing with it the
predicted tolerance to high heat7.
Compared to other known chaperones, the
mechanism of Hsp104 is unique. Rather than
preventing improper folding of newly made or
denatured proteins, Hsp104 breaks up protein
aggregates that may form when proteins denature at
high heat8.
An exquisite example of form meets function, Hsp104
becomes arranged into ring-shaped hexamers in the
presence of ATP5. This shape immediately brings to
mind the barrel shapes of Hsp60 and proteasomes,
both of which engulf other proteins to either help them
fold or digest them9.
Figure 1.  The [PSI+] phenotype
In [psi-] (normal) cells, Sup35 works in conjunction with Sup45 to terminate protein translation. In [PSI+] cells, the N-termini of Sup35
aggregate, meaning there is less Sup35 available for translation termination and the ribosome reads through some stop codons. Adapted
from Uptain and Lindquist (2002).
The prion connection
Two yeast factors discovered in the 60’s and 70’s,
[PSI+] and [URE3], showed a strange pattern of
inheritance that could not be explained until recently9.
Instead of the 3:1 ratio expected from Mendelian
inheritance, these factors showed a 1:1:1:1 inheritance;
that is, if the parent cell displayed either of these
phenotypes, all four progeny did too. One possible
explanation for the [PSI+]/[URE3] phenomenon was put
forth in 1994 when Reed Wickner made the brilliant
suggestion that perhaps, akin to the infectivity seen in
mammalian prions, these factors followed a protein-only
pattern of inheritance11.
Several lines of evidence supported this
hypothesis. For one, overexpression of Sup35 results in
[PSI+] cells12, just as overexpression of PrP results in
prion disease in mice13. For another, both of these
factors are metastable, spontaneously disappearing at
rates higher than expected from random mutations10.
Finally, cells can be “cured” of these factors through low
concentrations of guanidine hydrochloride, a protein
denaturant10.
The [PSI+] phenotype results in some stop
codons being read through (Fig. 1). It is the product of
the Sup35 protein10, which, along with Sup45, makes
up the translation termination factor14 (Fig. 1). The
[URE3] phenotype causes cells to take up catabolites
during nitrogen abundance that it normally takes up
only during nitrogen starvation11. It is associated with
the protein Ure2, which prevents transcription of a
certain catabolite transporter when nitrogen is
abundant10.
As described above, prions were first defined
as proteins capable of a protein-only model of
infectivity. Wickner’s proposal broadened this definition
to include a protein-only model of inheritance while
challenging the dogma that only nucleic acids can act
as genetic elements.
Hsp104 and [PSI+]
The burgeoning field of yeast prions abruptly became of
the utmost interest to my lab when its relationship with
a now familiar member of my work, Hsp104, was
revealed. The connection was made when Yury
Chernoff, working in association with Bun-ichiro Ono,
Sergei Inge-Vechtomov, and Susan W. Liebman,
screened an S. cerevisiae genomic library for genes
that modified [PSI+]. Just one clone from this library
suppressed the [PSI+] phenotype: Hsp10415.
As it turns out, Hsp104’s relationship with
[PSI+] is rather paradoxical: while overexpression of this
chaperone makes [PSI+] cells [psi-], so does removing
Hsp104 altogether15. In fact, once the plasmid bearing
Hsp104 is lost, cells are unable to become  [PSI+]15,
demonstrating the essential role of Hsp104 in
maintaining this phenotype.
Investigation of yeast prions immediately lent
support for the prion hypothesis that proteins can act as
genetic elements. The solubility of Sup35 correlates to
whether a cell is [PSI+] or [psi-]. In [psi-] cells, most
Sup35 is soluble while in [PSI+] cells, a substantial
portion of the Sup35 is insoluble16. [PSI+] cells contain
Sup35 aggregates in the cytosol detectable by GFP15.
That [PSI+] is caused by protein aggregates
immediately makes clear the role of Hsp104 in
mediating this phenotype, or at least in abrogating it
upon overexpression. The need for Hsp104 in
maintaining the [PSI+] is less easy to explain. One
possibility  is  that  this  chaperone  may convert normal
Sup35 protein to a form that forms aggregates (Figure 2
STOP
 occasional
readthrough
STOP Sup35 C
terminus
Sup35 N
terminus
STOP Stop
codon
Sup45
Ribosome
Protein
mRNA
mRNA
[psi—]
[PSI+]
Figure 2. A model for Sup35 conversion and assembly
In this model, an intermediate amount of Hsp104 converts soluble Sup35 to a less structured form that nucleates over time. This nucleus
then rapidly seeds further conversion. Overexpression of Hsp104 resolves Sup35, eliminating [PSI+].   
and below). The insolubility of these prions bears a
striking resemblance to the scrapie form of PrP1, as
does their resistance to proteolysis1,16.
Fiber formation in [PSI+]
Several mammalian diseases, such as the
transmissible spongiform encephalopathies,
Alzheimer’s disease, and Huntington’s disease are
characterized by the presence of amyloid fibers1.
Amyloid fibers contain high amounts of beta sheet and
can be identified by their ability to bind the dye Congo
red17. The NM region of Sup35 (i.e. the prion-
determining region, see below) spontaneously forms
amyloid fibers in vitro17. However, “seeding” the
reaction by adding a tiny amount of NM fiber greatly
increases the speed with which soluble Sup35 forms
fibers17. These experiments directly demonstrate the
ability of aggregated proteins to “pass on” a trait to
normal proteins.
Several possible models can potentially
explain the mechanism of fiber formation by Sup35.
However, kinetic analysis of fiber assembly supports a
model called nucleated conformational conversion. In
this model, less structured Sup35 slowly forms nuclei,
which then rapidly seed the nucleation of other Sup35
proteins18. Hsp104 may aid in the production of less
structured forms of Sup35 that are used to form nuclei18
(Figure 2).
The Sup35 prion-determining domain
Sup35 contains three domains with distinct properties.
The C-terminus (C) is soluble, conserved among
species, and is the only domain necessary for
translation termination17. The middle domain (M) is still
not well understood but appears to influence the
inheritance pattern of [PSI+]19.  The N-terminus (N) is
insoluble, unconserved, and unessential for biological
function17. Overexpression of this region results in
aggregates and makes cells [PSI+]; cells with this
region deleted can never be [PSI+]10. In short, N is
responsible for endowing Sup35 with all of its prion-like
traits.
The Sup35 N-terminus shows similarity to the
N-terminus of mammalian PrP in that it contains five
imperfect glutamine- and asparagine-rich oligopeptide
repeats17. Expanded polyglutamine repeats in the
protein huntingtin (Ht) are associated with Huntington’s
disease20. Such conservation suggests that these
repeats have an inherent tendency to aggregate.
Indeed, removing four of the five repeats from Sup35
results in the inability of cells to become [PSI+] while
inserting two more repeats enhances the [PSI+]
phenotype21. And Sup35 containing mutations in the
glutamine/asparagine-rich region greatly diminishes the
prion-forming capacity of ths protein, as found by my
colleague, Jonathan Weissman22.
We extended these findings by conducting
similar experiments on Ht in both yeast and
Caenorhabditis elegans. As predicted, with increasing
lengths of the polyglutamine repeat of Ht, the greater
the amount of insoluble Ht in the cell20, 23. In yeast,
deletion of Hsp104 eliminated aggregates while in both
systems, overexpression of Hsp104 reduced
aggregates20, 23.
The aggregation properties of NM are such
that we were able to take an unrelated protein, the
glucocorticoid receptor, and turn it into a prion simply by
fusing it with NM24. This experiment demonstrated that
NM is sufficient for inducing a prion-like state, and
provides unequivocal evidence for a protein-only
mechanism of inheritance.
Peculiarities of yeast
In addition to providing strong evidence supportive of
the prion hypothesis outlined by Prusiner1, yeast prions
have suggested solutions to questions that are harder
to address in mammals.
One of these questions surrounds the issue
of strains. If prion diseases are all caused by a single
protein, PrP, what can account for the different
pathologies seen in many of them? In yeast, different
[PSI+] strains can be distinguished based on their
differing degrees of stop codon suppression. The basis
for these strains lies in the efficiency with which they
convert Sup35 to the prion form. Weaker strains
convert Sup35 less efficiently, resulting in lower ratios
of soluble to insoluble Sup35 and less stop codon
suppression25.
In mammals, prions are harmful and so were
at first assumed to be the consequence of an aberrant if
not defective protein. In yeast, it appears that this is not
always the case. [PSI+] and [psi-] yeast grown in a
variety of conditions show different amounts of survival
that varies according to the strain and the conditions26.
For some strain-conditions combinations [PSI+] cells
survive more; for others, [psi-] cells survive more; and
for still others, [PSI+] state has no effect. Thus, [PSI+]
can spontaneously “turn on” different phenotypes,
aiding the survival of some cells and increasing the
overall survival of the population in changing
environments.
Prions abound
Once yeast prions and the essential features of their
prion-determining domain had been identified, it was a
simple matter of searching databases for proteins with
similar domains. Such searches turned up several other
candidate prion proteins in several species of fungus.
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We were able to confirm that one of these
candidates, [RNQ+], is in fact a prion: when the N-
terminus of its protein-determinant Rnq1 was
substituted for the N-terminus of Sup35, this
recombinant Sup35 made cells [PSI+]27. The protein
chaperone Sis1, part of the Hsp40 family, is necessary
for maintenance of [RNQ+]28. Several other putative
prions have yet to be well characterized29.
Another prion, [PIN+] ([PSI+] inducibility
factor), was first identified not via homology but by its
ability to substantially increase the appearance of
[PSI+]29. Overexpression of both Sup35 and Rnq1
makes [pin-] cells [PIN+]29.
Another prion, [HET-s], found in the
filamentous fungus Podospora anserina29, takes the
finding that prions are not always harmful even farther.
Whereas [PSI+] is advantageous to budding yeast
under certain conditions, [HET-s] is necessary to
prevent lethal fusion of mycelia of incompatible
strains29.
The widespread presence and diverse roles
of prions suggests that the tendency of certain proteins
to misfold has frequently been exploited by cells and
that the aberrant appearance of mammalian prions may
be the exception rather than the rule. 
Findings in mammalian prions
In the past seven years, my lab has spent some time
investigating mammalian prions and their relationships
to chaperones. The protein that gives rise to
mammalian prions, PrP, can exist in two forms: the
soluble, protease-sensitive form (PrPC), and the
insoluble, protease-resistant form responsible for
disease (PrP Sc, named after one of the first known
prion diseases, scrapie)1. PrP is known to be a cell-
surface glycoprotein that is processed through the cell
secretory pathway, but its function remains a mystery30.
For reasons that are still unknown, PrPSc tends to
selectively accumulate in and kill neurons, even though
the normal form is ubiquitous1.
A series of in vitro experiments elucidated the
mechanics of PrP. We found that yeast Hsp104
interacts not only with Sup35 but with hamster PrP31.
Interestingly, whereas incubation of Hsp100 proteins
with a substrate normally increases their ATPase
activity, Sup35, PrP, and other amyloidogenic proteins
decreased Hsp104 ATPase activity31.  This
phenomenon suggests that Hsp104 reacts with prion-
like proteins in a manner that differs from its normal
chaperone function. The conversion of PrP to its
insoluble state is enhanced by Hsp104 and another
chaperone, GroEL32. However, in addition to
chaperones, a small amount of pre-formed PrPSc is
necessary32.
Part of the reason for the toxicity of misfolded
PrP can be attributed to the inherent tendency of this
protein to misfold and accumulate in the cytosol33.
Proteins that have misfolded beyond repair in the
endoplasmic reticulum are often booted out into the
cytosol to be digested by proteasomes, a process
called retrograde transport33 .
In strong support of a retrograde transport
model, cells treated with proteasome inhibitors display
an accumulation of PrP in the cytosol33. What’s more,
the form of PrP that accumulates in the cytosol lacks an
N-terminal ER translocation signal peptide and C-
terminal GPI sequence, indicative of processing in the
ER but not the Golgi33. Increasing concentrations of
cytosolic PrP increases the formation of PrPSc 34 and
leads to increasing toxicity in neuroblastoma cells35,
suggesting that an overabundance of PrP overwhelms
the proteasomes, allowing PrPSc to spontaneously form.
Conclusion
In summary, yeast has provided a genetically tractable
system in which to study the genetics of prions. Our
studies have done much to support the prion
hypothesis and have even extended it to include a
protein-only mechanism of inheritance in addition to the
protein-only mechanism of infectivity seen in mammals.
Yeast have demonstrated that prions are a universal
phenomenon whose functions can differ greatly.
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